Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debora Bencivenga

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Cancer Letters|July 9, 2017
p27<sup>Kip1</sup> and human cancers: A reappraisal of a still enigmatic proteinDebora Bencivenga, Ilaria Caldarelli, Emanuela Stampone, et al.
International Journal of Molecular Sciences|October 26, 2024
p57<sup>Kip2</sup> Phosphorylation Modulates Its Localization, Stability, and InteractionsEmanuela Stampone, Debora Bencivenga, Luisa Dassi, et al.
Cells|February 12, 2025
p27<sup>Kip1</sup> and Tumors: Characterization of <i>CDKN1B</i> Variants Identified in MEN4 and Breast CancerDebora Bencivenga, Emanuela Stampone, Jahanzaib Azhar, et al.
Cellular and Molecular Life Sciences : CMLS|July 21, 2023
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategyEmanuela Stampone, Debora Bencivenga, Maria Chiara Capellupo, et al.
Plos One|December 14, 2011
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cellsAdriana Borriello, Ilaria Caldarelli, Maria Assunta Basile, et al.
Current Pharmaceutical Design|February 12, 2013
Resveratrol and cancer treatment: is hormesis a yet unsolved matter?Adriana Borriello, Debora Bencivenga, Ilaria Caldarelli, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinasesDebora Bencivenga, Annunziata Tramontano, Alessia Borgia, et al.
Molecular Cancer Research : MCR|August 6, 2011
p57(Kip2) and cancer: time for a critical appraisalAdriana Borriello, Ilaria Caldarelli, Debora Bencivenga, et al.
Talanta|January 29, 2023
Towards a point-of-care test to cover atto-femto and pico-nano molar concentration ranges in interleukin 6 detection exploiting PMMA-based plasmonic biosensor chipsNunzio Cennamo, Angelantonio Piccirillo, Debora Bencivenga, et al.
Free Radical Biology & Medicine|February 25, 2023
Plasmonic optical fiber biosensor development for point-of-care detection of malondialdehyde as a biomarker of oxidative stressDebora Bencivenga, Francesco Arcadio, Angelantonio Piccirillo, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cancer Letters|July 9, 2017
p27<sup>Kip1</sup> and human cancers: A reappraisal of a still enigmatic proteinDebora Bencivenga, Ilaria Caldarelli, Emanuela Stampone, et al.
International Journal of Molecular Sciences|October 26, 2024
p57<sup>Kip2</sup> Phosphorylation Modulates Its Localization, Stability, and InteractionsEmanuela Stampone, Debora Bencivenga, Luisa Dassi, et al.
Cells|February 12, 2025
p27<sup>Kip1</sup> and Tumors: Characterization of <i>CDKN1B</i> Variants Identified in MEN4 and Breast CancerDebora Bencivenga, Emanuela Stampone, Jahanzaib Azhar, et al.
Cellular and Molecular Life Sciences : CMLS|July 21, 2023
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategyEmanuela Stampone, Debora Bencivenga, Maria Chiara Capellupo, et al.
Plos One|December 14, 2011
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cellsAdriana Borriello, Ilaria Caldarelli, Maria Assunta Basile, et al.
Current Pharmaceutical Design|February 12, 2013
Resveratrol and cancer treatment: is hormesis a yet unsolved matter?Adriana Borriello, Debora Bencivenga, Ilaria Caldarelli, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinasesDebora Bencivenga, Annunziata Tramontano, Alessia Borgia, et al.
Molecular Cancer Research : MCR|August 6, 2011
p57(Kip2) and cancer: time for a critical appraisalAdriana Borriello, Ilaria Caldarelli, Debora Bencivenga, et al.
Talanta|January 29, 2023
Towards a point-of-care test to cover atto-femto and pico-nano molar concentration ranges in interleukin 6 detection exploiting PMMA-based plasmonic biosensor chipsNunzio Cennamo, Angelantonio Piccirillo, Debora Bencivenga, et al.
Free Radical Biology & Medicine|February 25, 2023
Plasmonic optical fiber biosensor development for point-of-care detection of malondialdehyde as a biomarker of oxidative stressDebora Bencivenga, Francesco Arcadio, Angelantonio Piccirillo, et al.
Pageof 4